SingleCell Biotechnology
SingleCell Biotechnology offers a platform that helps researchers and pharma companies study cancer at the single-cell level to inform drug development. The core tech combines single-cell sequencing, multiomic analysis, and machine learning on a micro-fabricated platform that isolates dormant, clonogenic, and migratory phenotypes, with 3-D label-free imaging via SCI-AP. The category is a B2B precision oncology platform that integrates with standard lab workflows and enables drugs discovery collaborations and CRO partnerships. The system targets high-relapse oncology markets and scalable clinical research and platform expansion.
SingleCell Biotechnology
SingleCell Biotechnology offers a platform that helps researchers and pharma companies study cancer at the single-cell level to inform drug development. The core tech combines single-cell sequencing, multiomic analysis, and machine learning on a micro-fabricated platform that isolates dormant, clonogenic, and migratory phenotypes, with 3-D label-free imaging via SCI-AP. The category is a B2B precision oncology platform that integrates with standard lab workflows and enables drugs discovery collaborations and CRO partnerships. The system targets high-relapse oncology markets and scalable clinical research and platform expansion.